Liberty Health Sciences to be exclusive distributor of Isodiol International products throughout Florida and Massachusetts
Liberty Health Sciences Inc. (CSE: LHS) (OTCQX: LHSIF) is pleased to announce that it has signed a licensing agreement with Isodiol International Inc., a leader in pharmaceutical grade phytochemical compounds and the industry leader in the manufacturing and development of CBD consumer products, to provide a complementary suite of medical... Read more
Aurora Cannabis Launches New Cannabis Product Line – Aurora Frost
Aurora Cannabis Inc. (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) today announces the launch of new product line called Aurora Frost. This new dried cannabis product line represents the highest potency offering of any Aurora product launched to date at over 35% THC. Aurora Frost products are produced from premium whole flower.... Read more
Canopy Growth Corporation announces entry into the African market with acquisition of Daddy Cann Lesotho
Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) is pleased to announce that the Company has acquired Daddy Cann Lesotho PTY Ltd., trading as Highlands. Based in the Kingdom of Lesotho (“Lesotho”), Highlands holds a license to cultivate, manufacture, supply, hold, import, export and transport cannabis and its resin. Lesotho is a high altitude mountainous kingdom... Read more
The Green Organic Dutchman to Exclusively License Fast-Acting Stillwater Foods’ RIPPLE SC (Soluble Cannabinoids) and Other Proprietary Beverage and Food Technologies
The Green Organic Dutchman Holdings Ltd. (TSX:TGOD) is pleased to announce  that the Company has entered into an exclusive agreement with Stillwater Brands to license RIPPLE SC (Soluble Cannabinoids) ingredient technology, and other proprietary beverage and food technologies and formulations related to cannabinoid-infused consumer packaged goods including micro-dose and... Read more
MedReleaf and BioPharma Services Inc. announce Strategic Alliance
MedReleaf Corp. (TSX: LEAF) and BioPharma Services Inc. today announced they have entered into an exclusive agreement to conduct clinical research for cannabis and cannabis derived products. Under the agreement BioPharma will become an extension of MedReleaf’s clinic development team.  BioPharma will provide medical, clinical, pharmacological and lab expertise to... Read more
Harvest One announces Aldergrove BC Expansion site
Harvest One Cannabis Inc. (TSXV: HVT) is pleased to advise that its wholly owned subsidiary, United Greeneries, has entered into a five-year lease agreement, with three five year renewal options, for a lower mainland site that will meet all previous announced capacity targets. The Company has ended its option to... Read more
Dr. Mark Ware Joins Canopy Growth Corporation as Chief Medical Officer
Canopy Growth Corporation (TSX: WEED, NYSE: CGC) is pleased to announce that Dr. Mark Ware, a leading researcher in the cannabis field for decades, will join the senior leadership team at Canopy Growth as the Company’s Chief Medical Officer commencing July 1st, 2018. Dr. Ware is an associate professor of family medicine... Read more
Aphria Forms Landmark Venture with South African Company Verve Group of Companies
Aphria Inc. (TSX: APH and US OTC: APHQF) today announced that it has entered into a series of agreements resulting in Aphria forming a joint venture, CannInvest Africa Ltd., with South African company Verve Group of Companies. As part of this transaction CannInvest will acquire an interest in Verve Dynamics Inc., a... Read more
Aurora Cannabis Signs Agreement with Heinrich Klenk GmbH & Co. KG
Aurora Cannabis Inc. (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) today announced that the Company, through its wholly owned subsidiary Pedanios GmbH, has signed a collaboration agreement with Heinrich Klenk GmbH & Co. KG, one of Europe’s largest medicinal plant companies. Klenk, whose products are carried in over 25,000 pharmacies throughout Germany and Europe,... Read more
Pharmacists urge Senate to include more support for patients as they consider Bill C-45 to legalize cannabis
With the legalization of recreational cannabis looming on the horizon, the Canadian Pharmacists Association (CPhA), joined by the Association québécoise des pharmaciens propriétaires (AQPP), appeared today before the Standing Senate Committee on Social Affairs, Science and Technology to discuss Bill C-45. Pharmacists are asking the Senate to include more... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )